Thornal Kevin R
- SEC CIK
- 0001783992
In the past year, 1 open-market sale filing worth $529.0K and no purchases.
Current role at each company
- ZBH Zimmer Biomet Holdings, Inc.Grp Pres-Global Businessas of Sep 15, 2026
- NVRO Nevro CorpPresident & CEOas of Apr 3, 2025
- HOLX Hologic IncGroup Pres, Global Diagnosticsas of Nov 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $529.0K
- 1 filing
- Net
- −$529.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Thornal Kevin R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZBH Zimmer Biomet Holdings, Inc.
Grp Pres-Global Business1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)4:24 PM ET | Sep 11 | 4 days | Thornal Kevin RGrp Pres-Global Business | SSale | −5.69K | $92.95 | −$529.0K | −100.0%0 after |
HOLX Hologic Inc
Group Pres, Global Diagnostics1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 (view filing) | Nov 15 | 2 days | Thornal Kevin RGroup Pres, Global Diagnostics | SSale | −19.1K | $75.32 | −$1.44M | −23.5%62.4K after | 2 lots |